Does CERTOLIZUMAB PEGOL Cause Mobility decreased? 3,202 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 3,202 reports of Mobility decreased have been filed in association with CERTOLIZUMAB PEGOL (Cimzia). This represents 3.2% of all adverse event reports for CERTOLIZUMAB PEGOL.
3,202
Reports of Mobility decreased with CERTOLIZUMAB PEGOL
3.2%
of all CERTOLIZUMAB PEGOL reports
1,539
Deaths
1,749
Hospitalizations
How Dangerous Is Mobility decreased From CERTOLIZUMAB PEGOL?
Of the 3,202 reports, 1,539 (48.1%) resulted in death, 1,749 (54.6%) required hospitalization, and 1,649 (51.5%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERTOLIZUMAB PEGOL. However, 3,202 reports have been filed with the FAERS database.
What Other Side Effects Does CERTOLIZUMAB PEGOL Cause?
Drug ineffective (23,838)
Rheumatoid arthritis (17,782)
Pain (13,929)
Fatigue (11,438)
Off label use (10,281)
Rash (9,663)
Alopecia (9,111)
Maternal exposure during pregnancy (9,013)
Arthralgia (8,993)
Abdominal discomfort (8,615)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which CERTOLIZUMAB PEGOL Alternatives Have Lower Mobility decreased Risk?
CERTOLIZUMAB PEGOL vs CERTOPARIN
CERTOLIZUMAB PEGOL vs CETIRIZINE
CERTOLIZUMAB PEGOL vs CETIRIZINE\PSEUDOEPHEDRINE
CERTOLIZUMAB PEGOL vs CETRIMIDE
CERTOLIZUMAB PEGOL vs CETRORELIX